Sam Keeping

7PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 19, 2026
Randomized Controlled Trials Comparing the Standard of Care to Alternative Treatments in Patients with Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma: A Systematic Literature Review.

|Sep 25, 2025
Meta-analysis to Investigate the Correlation Between Event-Free Survival and Overall Survival in Patients with Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma.

Dandan Zheng, Ali Mojebi, Yuexin Tang

|Apr 24, 2025
Pembrolizumab with Carboplatin and Paclitaxel Versus Alternative Systemic Treatments Recommended for the First-Line Treatment of Recurrent/Metastatic Head and Neck Cancer: An Indirect Treatment Comparison.

Marcin Dzienis, Ali Mojebi, Sam Keeping

|Oct 16, 2023
Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma.

Georg Hess, Martin Dreyling, Lucie Oberic

|Oct 18, 2022
Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review study.

Georg Hess, Martin Dreyling, Lucie Oberic

|Sep 01, 2022
Matching-adjusted indirect comparison of axi-cel and liso-cel in relapsed or refractory large B-cell lymphoma.

Olalekan O Oluwole, Jenny M H Chen, Keith Chan

Pageof 2

Frequent Collaborators

3 joint publications

Dandan Zheng

3 joint publications

Ali Mojebi

2 joint publications

Jenny M H Chen

1 joint publications

He Jin